NDC Code(s) : 68382-529-42, 68382-529-60
Packager : Zydus Pharmaceuticals (USA) Inc.
Category : HUMAN PRESCRIPTION DRUG LABEL
DEA Schedule : none
Marketing Status : New Drug Application
INGREDIENTS AND APPEARANCE
CHOLESTYRAMINECHOLESTYRAMINE POWDER, FOR SUSPENSION | |||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
|
LABELER - Zydus Pharmaceuticals (USA) Inc.(156861945) |
REGISTRANT - Zydus Pharmaceuticals (USA) Inc.(156861945) |
Establishment | |||
Name | Address | ID/FEI | Business Operations |
Zydus Lifesciences Limited | 677605858 | ANALYSIS(68382-529), MANUFACTURE(68382-529) |
PRINCIPAL DISPLAY PANEL
NDC 68382-529-42
Cholestyramine for Oral Suspension USP Light Powder, 4 gm
Rx only
231 gm
ZYDUS
NDC 68382-529-60
Cholestyramine for Oral Suspension USP Light Powder, 4 gm
Rx only
60 Pouch
ZYDUS